PL1638971T3 - Wytwarzanie podstawionych chinoksalin z dianiliny i 2,3-dihydroksy-1,4-dioksanu - Google Patents

Wytwarzanie podstawionych chinoksalin z dianiliny i 2,3-dihydroksy-1,4-dioksanu

Info

Publication number: PL1638971T3
Authority: PL; Poland
Prior art keywords: dianiline; dihydroxy; dioxane; preparation; substituted quinoxalines
Prior art date: 2003-06-04

Application number

PL04734570T

Other languages

English (en)

Inventor

Joseph Philip Rainville

Geraldine Patricia Taber

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-06-04

Filing date

2004-05-24

Publication date

2009-01-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33511699&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1638971(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-05-24 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2009-01-30 Publication of PL1638971T3 publication Critical patent/PL1638971T3/pl

Links

YLVACWCCJCZITJ-UHFFFAOYSA-N 1,4-dioxane-2,3-diol Chemical compound OC1OCCOC1O YLVACWCCJCZITJ-UHFFFAOYSA-N 0.000 title 1
QGMGHALXLXKCBD-UHFFFAOYSA-N 4-amino-n-(2-aminophenyl)benzamide Chemical compound C1=CC(N)=CC=C1C(=O)NC1=CC=CC=C1N QGMGHALXLXKCBD-UHFFFAOYSA-N 0.000 title 1
150000003252 quinoxalines Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

PL04734570T 2003-06-04 2004-05-24 Wytwarzanie podstawionych chinoksalin z dianiliny i 2,3-dihydroksy-1,4-dioksanu PL1638971T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US47558903P	2003-06-04	2003-06-04
PCT/IB2004/001787 WO2004108725A1 (en)	2003-06-04	2004-05-24	Preparation of substituted quinoxalines from the dianline with 2,3-dihydroxy-1,4-dioxane
EP04734570A EP1638971B1 (en)	2003-06-04	2004-05-24	Preparation of substituted quinoxalines from the dianiline with 2,3-dihydroxy-1,4-dioxane

Publications (1)

Publication Number	Publication Date
PL1638971T3 true PL1638971T3 (pl)	2009-01-30

Family

ID=33511699

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL378491A PL378491A1 (pl)	2003-06-04	2004-05-24	Sposób wytwarzania podstawionych chinoksalin z dianiliny i z 2,3-dihydroksy-1,4-dioksanu
PL04734570T PL1638971T3 (pl)	2003-06-04	2004-05-24	Wytwarzanie podstawionych chinoksalin z dianiliny i 2,3-dihydroksy-1,4-dioksanu

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL378491A PL378491A1 (pl)	2003-06-04	2004-05-24	Sposób wytwarzania podstawionych chinoksalin z dianiliny i z 2,3-dihydroksy-1,4-dioksanu

Country Status (17)

Country	Link
US (1)	US20070185327A1 (pl)
EP (1)	EP1638971B1 (pl)
JP (1)	JP2006526607A (pl)
AR (1)	AR044472A1 (pl)
AT (1)	ATE405566T1 (pl)
BR (1)	BRPI0410613A (pl)
CA (1)	CA2527337A1 (pl)
CL (1)	CL2004001271A1 (pl)
DE (1)	DE602004015986D1 (pl)
DK (1)	DK1638971T3 (pl)
ES (1)	ES2310730T3 (pl)
MX (1)	MXPA05013084A (pl)
PL (2)	PL378491A1 (pl)
PT (1)	PT1638971E (pl)
SI (1)	SI1638971T1 (pl)
TW (1)	TWI251594B (pl)
WO (1)	WO2004108725A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX2007010375A (es) *	2005-02-24	2007-09-25	Pfizer Prod Inc	Preparacion de quinoxalina sustituida de elevada pureza.
US8039620B2 (en)	2008-05-22	2011-10-18	Teva Pharmaceutical Industries Ltd.	Varenicline tosylate, an intermediate in the preparation process of varenicline L-tartrate
US20090318695A1 (en) *	2008-06-19	2009-12-24	Vinod Kumar Kansal	Processes for the preparation of varenicline and intermediates thereof
US8314235B2 (en)	2008-09-01	2012-11-20	Actavis Group Ptc Ehf	Process for preparing varenicline, varenicline intermediates, pharmaceutically acceptable salts thereof
EP2438054A1 (en)	2009-06-22	2012-04-11	Teva Pharmaceutical Industries Ltd.	Solid states forms of varenicline salts and processes for preparation thereof
EP2545054A1 (en)	2010-03-09	2013-01-16	Actavis Group Ptc Ehf	Highly pure varenicline or a pharmaceutically acceptable salt thereof substantially free of methylvarenicline impurity
US20120004239A1 (en)	2010-06-11	2012-01-05	Medichem, S.A.	Process for Preparing Quinoxaline Derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RS50069B (sr) *	1997-12-31	2009-01-22	Pfizer Products Inc.,	Aril kondenzovana azapoliciklična jedinjenja
US6605610B1 (en) *	1997-12-31	2003-08-12	Pfizer Inc	Aryl fused azapolycyclic compounds
WO2002085843A2 (en) *	2001-04-20	2002-10-31	Pfizer Products Inc.	Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds

2004
- 2004-05-24 WO PCT/IB2004/001787 patent/WO2004108725A1/en not_active Ceased
- 2004-05-24 DK DK04734570T patent/DK1638971T3/da active
- 2004-05-24 PT PT04734570T patent/PT1638971E/pt unknown
- 2004-05-24 BR BRPI0410613-0A patent/BRPI0410613A/pt not_active IP Right Cessation
- 2004-05-24 ES ES04734570T patent/ES2310730T3/es not_active Expired - Lifetime
- 2004-05-24 AT AT04734570T patent/ATE405566T1/de not_active IP Right Cessation
- 2004-05-24 EP EP04734570A patent/EP1638971B1/en not_active Expired - Lifetime
- 2004-05-24 DE DE602004015986T patent/DE602004015986D1/de not_active Expired - Fee Related
- 2004-05-24 MX MXPA05013084A patent/MXPA05013084A/es unknown
- 2004-05-24 CA CA002527337A patent/CA2527337A1/en not_active Abandoned
- 2004-05-24 SI SI200430846T patent/SI1638971T1/sl unknown
- 2004-05-24 JP JP2006508421A patent/JP2006526607A/ja not_active Withdrawn
- 2004-05-24 PL PL378491A patent/PL378491A1/pl not_active Application Discontinuation
- 2004-05-24 PL PL04734570T patent/PL1638971T3/pl unknown
- 2004-05-25 CL CL200401271A patent/CL2004001271A1/es unknown
- 2004-06-01 TW TW093115706A patent/TWI251594B/zh not_active IP Right Cessation
- 2004-06-02 US US10/858,600 patent/US20070185327A1/en not_active Abandoned
- 2004-06-03 AR ARP040101901A patent/AR044472A1/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
CA2527337A1 (en)	2004-12-16
PL378491A1 (pl)	2006-05-02
TWI251594B (en)	2006-03-21
JP2006526607A (ja)	2006-11-24
MXPA05013084A (es)	2006-03-02
DE602004015986D1 (de)	2008-10-02
EP1638971B1 (en)	2008-08-20
ATE405566T1 (de)	2008-09-15
PT1638971E (pt)	2008-10-23
ES2310730T3 (es)	2009-01-16
DK1638971T3 (da)	2008-10-27
BRPI0410613A (pt)	2006-06-20
AR044472A1 (es)	2005-09-14
US20070185327A1 (en)	2007-08-09
EP1638971A1 (en)	2006-03-29
TW200500365A (en)	2005-01-01
SI1638971T1 (sl)	2008-12-31
CL2004001271A1 (es)	2005-04-22
WO2004108725A1 (en)	2004-12-16

Publication	Publication Date	Title
HUS1800018I1 (hu)	2018-05-28	Antivirális tulajdonságú szubsztituált dihidrokinazolinok
AU2003286870A8 (en)	2005-01-04	Targeting polypeptides to the central nervous system
EP1617807A4 (en)	2007-02-21	SUBSTITUTED 1,4-DIAZEPINE AND ITS USES
AU2003301066A8 (en)	2004-09-06	Al2o3-la2o3-y2o3-mgo ceramics, and methods of making the same
AP2005003370A0 (en)	2005-09-30	Novel crystalline modification of the anhydrate ofboscalid.
EP1596807A4 (en)	2008-05-21	IMMUNE REGULATION BASED ON TARGETING EARLY ACTIVATION MOLECULES
SI1514871T1 (sl)	2016-02-29	Dispiro 1,2,4 - trioksolanski antimalariki
AU2003236720A8 (en)	2003-12-31	Substituted diaminopyrimidines
PT1638971E (pt)	2008-10-23	Preparação de quinoxalinas substituídas a partir da dianilina com 2,3-di-hidroxi-1,4-dioxano
GB0325295D0 (en)	2003-12-03	Improved cookware
ZA200505352B (en)	2007-01-31	Novel substituted 2,3-benzodiazepine derivatives
EP1723125A4 (en)	2009-11-18	1,2,4-benzotriazine-1,4-dioxides
AU2003294190A1 (en)	2005-07-05	The shower head
IL186226A0 (en)	2008-01-20	(3,4-dihydro-quinazolin-2-yl)-indan-1-yl-amines
GB0326991D0 (en)	2003-12-24	Pigments
AU2003238501A8 (en)	2003-12-31	Hybridization chamber
TWI365874B (en)	2012-06-11	One-pot process for the preparation of 1,2-benz-isoxazole-3-methanesulfonamide
TW573602U (en)	2004-01-21	Avstract of the disclosrte
EG23305A (en)	2004-11-30	Preparation of 1,2-dicloroethane.
GB0328229D0 (en)	2004-01-07	Improved chamber
GB0321923D0 (en)	2003-10-22	Ring clip
GB0323081D0 (en)	2003-11-05	Chamber arrangement
TJ20030800A (en)	2005-07-14	The method of formation of implastructional gunstock.
TW592087U (en)	2004-06-11	The improvement of cup
GB0327745D0 (en)	2003-12-31	The invisible mousemat